Abstract
The neurophysiologic and neuropsychologic effects and their relation to the kinetics of diazepam (DZ) were studied in 10 patients with impaired liver function of various degrees and in three normal subjects after 10 mg DZ i.v. The plasma concentration data were treated according to a two-compartment open model. Neurophysiologic effect measurements were obtained from galvanic skin response, continuous reaction times (CRT), heart rate, and averaged evoked potentials; neuropsychologic measurements were obtained from trail making A+B, hidden pattern, word fluency, and subtraction tests; in addition, clinical effects were rated by Beechers Mood Scale and Spielbergers Anxiety Scale. Except for trail making A and word fluency all tests discriminated well between the experimental conditions with or without diazepam. No difference from normal in the response to acute diazepam administration could be detected in patients with reduced liver function. A linear correlation between prolongation in CRT and DZ log plasma concentration was demonstrated in the entire, heterogenous patient material. In the clinical ratings only items of a predominantly sedative and autonomic significance responded to the diazepam injection, while predominantly anxiolytic items did not.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arnold, E.: A simple method for determining diazepam and its major metabolites in biological fluids: Application in biovailability studies. Acta pharmacol. (Kbh.) 36, 335–352 (1975)
Beecher, H. K., Measurement of subjective responses New York: Oxford University Press 1959
Berlin, A. B., Siwers, B., Agurell, S., Hiort, A., Sjöqvist, F., Ström, S. Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Clin. Pharmacol. Ther. 13, 733–744 (1973)
Bianchi, G. N., Fennessy, M. R., Philips, J., Everitt, B. S.: Plasma level of diazepam as a therapeutic predictor in anxiety states. Psychopharmacologia (Berl.) 35, 113–122 (1974)
Brun, P., Parsons, O. A.: Continuous reaction times in brain damage. Cortex 7, 278–291 (1971)
Buch Andreasen, P., Hendel, J., Greisen, G., Hvidberg, E. F.: Pharmacokinetics of diazepam in disordered liver function. Europ. J. clin. Pharmacol. (in press 1976)
Dasberg, H. H., van der Kleijn, E., Guelen, P. J. R., van Praag, H. M.: Clin. Pharmacol. Ther. 15, 473–483 (1974)
Garattini, S., Marcucci, F., Morselli, P. L., Mussini, E.: The significance of measuring blood levels of benzodiazepines. In: Biological effects of drugs in relation to their plasma concentrations, D. S. Davies and B. N. C. Prichard, eds., pp. 211–225. London: MacMillan 1973
Ghoneim, M. M., Mewaldt, S. P., Ambre, J.: Plasma levels of diazepam and mood ratings. Anesth. Analg. 54, 173–177 (1975)
Gibaldi, M., Perrier, D.: Pharmacokinetics, Vol. I. New York: Marcel Decker 1975
Harder, F., Elsass, P., Hendel, J., Hvidberg, E. F., Hjørting Hansen, E.: Clinical and psychological effects of intravenous diazepam related to plasma levels. A controlled double blind, crossover study in oral surgery involving local analgesia. Int. J. oral Surg. (in press 1976)
Hendel, J.: Cumulation in cerebrospinal fluid of the N-desmethyl metabolite after long-term treatment with diazepam in man. Acta pharmacol. (Kbh.) 37, 17–32 (1975)
hillestad, L., Hansen, T., Melsen, H., Drivener, A.: Diazepam metabolism in normal man. Clin. Pharmacol. Ther 16, 485–489 (1974)
Van der Kleijn, E.: Pharmacokinetics of distribution and metabolism of ataractic drugs and an evaluation of the site of antianxiety activity. Ann. N. Y. Acad. Sci. 179, 115–125 (1971)
Van der Kleijn E., Guelen, P. J. M., Beelen, T. C. M., Rijnties, N. V. M., Zuidgeest, T. L. B.: Kinetics of general and regional brain distribution of closely related 7-chloro-1,4-benzodiazepines. In: The benzodiazepines, S. Garattini, E. Mussini, and L. O. Randall, eds., pp. 145–164. New York: Raven Press 1973
Klotz, U., Uvant, G. R., Hoyumpa, A., Achenker, S., Wilkinson, G. R.: The effect of age and liver disease on the disposition and elimination of diazepam in adult man. J. clin. Invest. 55, 347–359 (1975)
Laidlaw, J., Read, A. E., Sherlock, S.: Morphine tolerance in hepatic cirrhosis. Gastroenterology 40, 389–396 (1961)
Morgan, M. H., Read, A. E.: Antidepressants and liver disease. Gut 13, 697–701 (1972)
Morselli, P. L., Cassano, G. B., Placidi, G. F., Muscettola, G. B., Rizzo, M.: Kinetics of the distribution of 14C-Diazepam and its metabolites in various areas of cat brain. In: The benzodiazepines, S. Garattini, E. Mussini, and L. O. Randall, eds., pp. 129–143. New York: Raven Press 1973
Read, A. E., Laidlaw, J., McCarthy, C. F.: Effects of chlorpromazine in patients with hepatic disease. Brit. med. J. 1969III, 497–499
De Renzi, E., Faglioni, P.: The comparative efficiency of intelligence and vigilance test in detecting hemispheric cerebral damage. Cortex 1, 410–433 (1965)
Riegelmann, S., Loo, J. C. K., Rowland, M.: Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J. pharm. Sci. 57, 717–756 (1968)
Siegel, S.: Non parametric statistics. New York: McGraw Hill 1956
Spielberger, C. D., Gorsuch, R. L., Lushene, R. E.: STAI manual for the state-trail anxiety inventory. Consulting Psychologists Press, Inc. Calif. 1970
Tansella, M., Siciliani, O., Burti, L., Schiavon, M., Zimmermann Tansella, Ch., Gerna, M., Tognoni, G., Morselli, P. L.: N-desmethyl-diazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels clinical efficacy and residual effects. Psychopharmacologia (Berl.) 41, 81–85 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hendel, J., Elsass, P., Andreasen, P.B. et al. Neuropsychologic effects of diazepam related to single dose kinetics and liver function. Psychopharmacology 48, 11–17 (1976). https://doi.org/10.1007/BF00423300
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00423300